Detalles de la búsqueda
1.
Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab.
J Headache Pain
; 25(1): 45, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38549121
2.
An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity.
J Headache Pain
; 25(1): 59, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637754
3.
Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment.
Headache
; 63(4): 484-493, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36753057
4.
The management of type 2 diabetes with fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy (insulin glargine U100 plus insulin aspart): A short-term cost-effectiveness analysis in the UK setting.
Diabetes Obes Metab
; 20(10): 2371-2378, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29797389
5.
Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention.
J Med Econ
; 26(1): 1072-1080, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594778
6.
Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS).
Neurol Ther
; 12(6): 2053-2065, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37728666
7.
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration.
J Comp Eff Res
; 12(7): e230021, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37222593
8.
Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial.
Expert Rev Pharmacoecon Outcomes Res
; 23(7): 797-803, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256558
9.
Long-Term Outcomes of Previously Treated Adult and Adolescent Patients with Severe Hemophilia A Receiving Prophylaxis with Extended Half-Life FVIII Treatments: An Economic Analysis from a United Kingdom Perspective.
Clinicoecon Outcomes Res
; 13: 39-51, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33500640
10.
Real-world utilities and health-related quality-of-life data in hemophilia patients in France and the United Kingdom.
Patient Prefer Adherence
; 13: 941-957, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31354248
11.
Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII.
Patient Prefer Adherence
; 13: 497-513, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31040652
12.
Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients.
Diabetes Ther
; 9(5): 1931-1944, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120755
13.
Systematic review: treatment pattern and clinical effectiveness and safety of pharmaceutical therapies for Crohn's disease in Europe.
Clin Exp Gastroenterol
; 9: 311-323, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27785086
Resultados
1 -
13
de 13
1
Próxima >
>>